FXI Rebounds Above 50-Day Average

That matters because China is once again leaning on the same policy playbook investors have seen before: liquidity injections, stock-market support measures and repeated attempts to steady sentiment after months of underperformance. Those measures can spark sharp rallies, but they do not erase the deeper problem. Investors still see a market trapped between stimulus on one side and structural doubts on the other — weak domestic demand, property-sector drag, and a policy regime that can support prices without necessarily restoring earnings growth.

The contrast across exchange-traded funds makes the point. The broader China ETF MCHI closed at 51.10, still under its 200-day moving average of 55.14, while the Shanghai-focused ASHR finished at 30.56, also below both its 50-day and 200-day averages. In other words, this is not a broad, conviction-driven re-rating of Chinese equities. It is a selective bid, vulnerable to headlines and policy smoke signals.

That is why commentary from well-known China watchers such as columnist Shuli Ren can become a market event in itself. In a market where investors are constantly searching for the next policy turn, a sharply written column can amplify either fear or optimism. When the narrative turns cautious, China stocks can sell off quickly; when the message hints at stabilization, they can rip higher just as fast. The market is not just trading earnings — it is trading interpretation.

For investors, that creates a distinct setup. The upside case in China is tied to a credible, sustained policy backstop and evidence that stimulus is finally translating into a stronger earnings cycle. The downside case is that policy support keeps arriving in bursts while the economy stays stuck in a low-confidence, low-multiple regime. That is why rallies in FXI, MCHI and ASHR deserve respect but not blind chase. Until the 200-day moving averages are reclaimed and held, this remains a tactical trade, not a long-term re-rating.

The more important investment implication is that the best opportunities may be outside the headline China bet. Investors looking for China exposure should favor companies with strong balance sheets, policy support and cash generation, while avoiding broad index exposure if they believe the macro backdrop is still too unstable. If stimulus deepens and sentiment improves, China equities could move fast. But if the market keeps reacting to every new column, policy rumor or geopolitical flare-up, volatility will remain the dominant feature — and the real alpha will go to those positioned early, not those waiting for confirmation.